[go: up one dir, main page]

DK119457B - Analogifremgangsmåde til fremstilling af hovedsagelig rene transisomere af p-aminoalkoksyfenylalkener. - Google Patents

Analogifremgangsmåde til fremstilling af hovedsagelig rene transisomere af p-aminoalkoksyfenylalkener.

Info

Publication number
DK119457B
DK119457B DK318667AA DK318667A DK119457B DK 119457 B DK119457 B DK 119457B DK 318667A A DK318667A A DK 318667AA DK 318667 A DK318667 A DK 318667A DK 119457 B DK119457 B DK 119457B
Authority
DK
Denmark
Prior art keywords
aminoalkoxyphenylalkenes
transisomers
preparation
substantially pure
analogous process
Prior art date
Application number
DK318667AA
Other languages
Danish (da)
English (en)
Inventor
D Richardson
Original Assignee
Ici Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ici Ltd filed Critical Ici Ltd
Publication of DK119457B publication Critical patent/DK119457B/da

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/13—Amines
    • A61K31/135—Amines having aromatic rings, e.g. ketamine, nortriptyline
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C43/00—Ethers; Compounds having groups, groups or groups
    • C07C43/02—Ethers
    • C07C43/03—Ethers having all ether-oxygen atoms bound to acyclic carbon atoms
    • C07C43/14—Unsaturated ethers
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02P—CLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
    • Y02P20/00—Technologies relating to chemical industry
    • Y02P20/50—Improvements relating to the production of bulk chemicals
    • Y02P20/55—Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
DK318667AA 1966-06-20 1967-06-20 Analogifremgangsmåde til fremstilling af hovedsagelig rene transisomere af p-aminoalkoksyfenylalkener. DK119457B (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GB27483/66A GB1128379A (en) 1966-06-20 1966-06-20 Novel alkene derivatives, process for the preparation thereof and compositions containing the same
GB2748367 1967-05-17

Publications (1)

Publication Number Publication Date
DK119457B true DK119457B (da) 1971-01-11

Family

ID=26258849

Family Applications (1)

Application Number Title Priority Date Filing Date
DK318667AA DK119457B (da) 1966-06-20 1967-06-20 Analogifremgangsmåde til fremstilling af hovedsagelig rene transisomere af p-aminoalkoksyfenylalkener.

Country Status (10)

Country Link
US (1) US3493606A (xx)
JP (1) JPS5026530B1 (xx)
BE (1) BE700166A (xx)
CH (1) CH507905A (xx)
CS (1) CS150543B2 (xx)
DK (1) DK119457B (xx)
FR (1) FR7070M (xx)
GB (1) GB1128379A (xx)
NL (1) NL6708487A (xx)
SE (1) SE339465B (xx)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4206234A (en) * 1977-08-22 1980-06-03 Imperial Chemical Industries Limited Triphenylbut-1-ene derivatives and pharmaceutical compositions and uses thereof
DE2860900D1 (en) 1977-08-22 1981-11-05 Ici Plc Triphenylalkene derivatives, process for their preparation and pharmaceutical compositions containing them
US5204337A (en) * 1988-10-31 1993-04-20 Endorecherche Inc. Estrogen nucleus derivatives for use in inhibition of sex steroid activity
US5219548A (en) * 1990-10-01 1993-06-15 Board Of Regents, The University Of Texas System High affinity halogenated-tamoxifen derivatives and uses thereof
ZA924811B (en) * 1991-06-28 1993-12-29 Endorecherche Inc Controlled release systems and low dose androgens
US5525633A (en) * 1993-09-24 1996-06-11 Merrell Dow Pharmaceuticals Inc. Triaryl-ethylene derivatives
US5681835A (en) * 1994-04-25 1997-10-28 Glaxo Wellcome Inc. Non-steroidal ligands for the estrogen receptor
US5691384A (en) * 1994-11-29 1997-11-25 Hoechst Marion Roussel, Inc. Method of using triaryl-ethylene derivatives in the treatment and prevention of osteoporosis
MX9703944A (es) * 1994-11-29 1998-05-31 Hoechst Marion Roussel Inc Metodo para usar derivados de triaril-etileno en el tratamiento y prevencion de osteoporosis.
KR20010022956A (ko) 1997-08-15 2001-03-26 듀크 유니버시티 에스트로겐-의존성 질병 및 장애의 예방방법 또는 치료방법

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NL100243C (xx) *
DE1155436B (de) * 1956-11-06 1963-10-10 Richardson Merrell Inc Verfahren zur Herstellung von 1-[p-(ª‰-Diaethylaminoaethoxy)-phenyl]-1, 2-diphenyl-2-chloraethylen

Also Published As

Publication number Publication date
SE339465B (xx) 1971-10-11
GB1128379A (en) 1968-09-25
DE1618565B2 (de) 1975-12-04
DE1618565A1 (de) 1970-10-29
CH507905A (de) 1971-05-31
JPS5026530B1 (xx) 1975-09-01
CS150543B2 (xx) 1973-09-04
BE700166A (xx) 1967-12-19
NL6708487A (xx) 1967-12-21
FR7070M (xx) 1969-06-30
US3493606A (en) 1970-02-03

Similar Documents

Publication Publication Date Title
DK133618B (da) Analogifremgangsmåde til fremstilling af 1-hydroxyaryl-2-aminoalkanoler.
DK122222B (da) Fremgangsmåde til fremstilling af alk-3-en-1-oler.
DK133783B (da) Fremgangsmåde til fremstilling af 7-halogen-7-desoxy-1-thio-alfa-D-galacto-octopyranosider.
DK124080B (da) Fremgangsmåde til fremstilling af D-6-metyl-8-cyanmetylergolin.
DK120698B (da) Analogifremgangsmåde til fremstilling af acetylguanidiner.
DK119457B (da) Analogifremgangsmåde til fremstilling af hovedsagelig rene transisomere af p-aminoalkoksyfenylalkener.
DK119307B (da) Fremgangsmåde til fremstilling af ketonitriler.
DK124886B (da) Fremgangsnmåde til fremstilling af 1-hydroxy-benzimidazol-N-oxider.
DK117954B (da) Fremgangsmåde til fremstilling af 3-amino-2-cyanoacrylamid.
DK122758B (da) Fremgangsmåde til fremstilling af α-methyl-multicyclo-methylaminer.
DK122522B (da) Fremgangsmåde til fremstilling af dichlorquinoliner.
DK123100B (da) Fremgangsmåde til fremstilling af N-tritylimidazoler.
DK115551B (da) Fremgangsmåde til fremstilling af 6-aminouracil-5-carbonamid-N-sulfonamider.
DK114063B (da) Fremgangsmåde til fremstilling af 1-methyl-2-isopropyl-5-nitro-imidazol.
DK120344B (da) Fremgangsmåde til fremstilling af 5-benzyl-pyrimidiner.
DK122761B (da) Analogifremgangsmåde til fremstilling af arylsulfonylurinstofderivater.
DK126378B (da) Analogifremgangsmåde til fremstilling af 17α-acyloxy-9α-chlor-11β-hydroxy-progesteroner.
DK119830B (da) Analogifremgangsmåde til fremstilling af arylsulfonylsemicarbazider.
DK114626B (da) Fremgangsmåde til fremstilling af 2-substitueret-4-amino-5-acylamidometylpyrimidin.
DK117568B (da) Analogifremgangsmåde til fremstilling af ftalazino-ftalazindioner.
DK122666B (da) Analogifremgangsmåde til fremstilling af hydrocortison-17-cyclopentancorboxylat.
DK119210C (da) Analogifremgangsmåde til fremstilling af ketoximethere.
DK121166B (da) Analogifremgangsmåde til fremstilling af 16-methyl-4-pregnen-3β-ol-20-oner.
DK114133B (da) Fremgangsmåde til fremstilling af 6-ketosteroider.
DK124405B (da) Fremgangsmåde til fremstilling af 2-trifluormethyl- eller 2-pentafluorethyl-benzimidazoler.